RISE 2_BHV7000-302

Project: Clinical studies › Clinical Study (Industry project)

Project Details

Description

A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy.
Short titleRISE 2
StatusActive
Effective start/end date13.08.2024 → 31.01.2027

Fields of science

  • 302052 Neurology